IMS Acquires PharmARC in India, Strengthening Global Services Capabilities

DANBURY, Conn.--(BUSINESS WIRE)-- IMS Health has acquired PharmARC, an India-based company specializing in commercial analytics and services for the life sciences industry. The acquisition adds significant scale to a world-class services delivery platform, strengthens IMS’s business process outsourcing capabilities, and complements IMS’s suite of proprietary technology and software applications.

PharmARC serves 15 of the top 20 global pharmaceutical companies and has experience delivering client engagements covering multiple therapeutic areas, geographies and data types. Through the acquisition, IMS will gain complementary services offerings, including robust key opinion leader analytics and social media monitoring capabilities. PharmARC also brings software engineering expertise to accelerate IMS innovation and offerings development.

“Life sciences companies are looking for partners that can pull together the right market and technology expertise, information assets and resources to help them optimize commercial operations worldwide,” says Chris Nickum, president, IMS Commercial Effectiveness Services. “We are uniquely positioned to address this need – with delivery scale and a range of technology and services offerings that include analytical and advisory services, business intelligence tools, mobile applications, data integration and management, and business process outsourcing.”

Supported by more than 7,000 dedicated resources worldwide, IMS’s services business includes analytics and delivery hubs in India, China and Bangladesh. Each year, IMS processes more than 36 billion healthcare transactions, covering every major market in the world, and generates 650,000 client deliverables. PharmARC contributes additional and complementary delivery resources to the IMS Delivery Center in Bangalore, and will help IMS meet the growing demand among pharmaceutical companies for outsourced services.

“We are truly excited to be joining a global healthcare leader like IMS as it expands its services business and leverages one-of-a-kind information, analytics and delivery capabilities to make clients more successful,” said Amit Sadana, co-founder and CEO of PharmARC. “Together, we’ll help customers improve the way they plan and execute commercial strategies anywhere in the world.”

About PharmARC

Founded in 2004 and based in Bangalore, India, PharmARC is a leading provider of analytic solutions for the efficient commercialization of drugs and medical products. The firm’s analytics and services enable its life sciences customers to make informed decisions related to their sales and marketing strategies and implementation, yielding better ROI. Additional information is available at www.pharmarc.com.

About IMS Health

IMS Health is the leading provider of information, services and technology for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, sophisticated analytics, on-shore and off-shore commercial services, and software platforms to help clients better understand the performance and value of medicines. With a presence in 100+ countries and more than 55 years of industry experience, IMS serves leading decision makers in healthcare, including pharmaceutical manufacturers and distributors, providers, payers, government agencies, policymakers, researchers and the financial community. Additional information is available at http://www.imshealth.com.



CONTACT:

IMS Health
Gary Gatyas, + 1-610-244-2600
[email protected]

KEYWORDS:   United States  Asia Pacific  North America  Connecticut  India

INDUSTRY KEYWORDS:   Technology  Software  Health  Biotechnology  Hospitals  Pharmaceutical  Other Health  Research  Science  General Health

MEDIA:

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.